Physician profile
James C Laughlin
NPI 1679775639
$4,367.49
in general payments reported to CMS, 2019-2025
9 companies · $1,526 in 2025
The $1,526 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,703 · 2020: $52.71 · 2022: $50.64 · 2023: $891 · 2024: $145 · 2025: $1,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Travel and Lodging: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.36 |
| Travel and Lodging | $1,232.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,517.80 | 2019-2020 | |
| Abbott Laboratories | $1,269.98 | 2019-2025 | Aveir, Ensite, Viewmate |
| Medtronic, INC. | $943.61 | 2023-2024 | Attain Command + Surevalve, Azure Xt Dr Mri Surescan, Selectsecure |
| Biotronik INC. | $266.38 | 2019-2025 | Rivacor 7 Dr-T |
| Impulse Dynamics (USA) INC. | $151.86 | 2025 | Optimizer |
| Boston Scientific Corporation | $143.15 | 2025 | Farapulse, Watchman Flx |
| Cardiva Medical, INC. | $38.64 | 2022 | |
| Irhythm Technologies, INC. | $21.07 | 2024 | Zio Monitor, Zio Xt Patch |
| Getinge USA Sales, LLC | $15.00 | 2023 | Cardiosave Hybrid, Type B Plug |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Laughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.